B dot Medical Inc., a medical device startup headquartered in Edogawa-ku, Tokyo, has successfully raised a total of JPY1.7 billion in Series A funding round through a third-party allocation of new shares and loans with venture capital firms and business companies as underwriters.
B dot Medical recently achieved the proof of concept of its ultra-compact proton therapy system, a key objective for the Series A funding. With the growing interest in proton therapy following the expansion of insurance coverage in April, 2021, B dot Medical is dedicated to realizing a society where everyone can choose proton therapy and is committed to expediting the sales start of the system.
Key Underwriters Include:
Keio Innovation Initiative Inc.,
Mitsubishi UFJ Capital Co., Ltd.,
and others.
Related Post:
Successful Proof of Concept for Ultra-compact Proton Therapy System
